Rimonabant and progression of atherosclerosis in obese persons

JAMA. 2008 Jul 16;300(3):280; author reply 280-1. doi: 10.1001/jama.2008.24.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Obesity Agents / therapeutic use
  • Atherosclerosis / diagnostic imaging
  • Atherosclerosis / prevention & control*
  • Coronary Artery Disease / complications
  • Coronary Artery Disease / drug therapy*
  • Ethics, Research
  • Humans
  • Obesity / complications
  • Obesity / drug therapy*
  • Piperidines / adverse effects
  • Piperidines / therapeutic use*
  • Placebos / therapeutic use
  • Pyrazoles / adverse effects
  • Pyrazoles / therapeutic use*
  • Receptor, Cannabinoid, CB1 / antagonists & inhibitors*
  • Research Design
  • Rimonabant
  • Ultrasonography

Substances

  • Anti-Obesity Agents
  • Piperidines
  • Placebos
  • Pyrazoles
  • Receptor, Cannabinoid, CB1
  • Rimonabant